Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1500 of 2400 entries
View as:

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00000837 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000730 Org: User:
Start: - End: 03/31/89 Due: 03/31/90

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Phase: N/A Priority: Normal
NCT ID: NCT00000913 Org: User:
Start: - End: 04/30/01 Due: 04/30/02

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Phase: N/A Priority: Normal
NCT ID: NCT00000826 Org: User:
Start: - End: 05/31/99 Due: 05/31/00

A Study to Test the Safety of Three Experimental HIV Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00000946 Org: User:
Start: - End: 03/31/01 Due: 03/31/02

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000712 Org: User:
Start: - End: 11/30/94 Due: 11/30/95

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000735 Org: User:
Start: - End: 02/28/90 Due: 02/28/91

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000820 Org: User:
Start: - End: 03/31/02 Due: 03/31/03

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000626 Org: User:
Start: - End: 02/28/99 Due: 02/28/00

A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

Phase: N/A Priority: Normal
NCT ID: NCT00000808 Org: User:
Start: - End: 09/30/98 Due: 09/30/99

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00000761 Org: User:
Start: - End: 10/31/97 Due: 10/31/98

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Phase: N/A Priority: Normal
NCT ID: NCT00000886 Org: User:
Start: - End: 04/30/99 Due: 04/30/00

Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT00000787 Org: User:
Start: - End: - Due: -

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

Phase: N/A Priority: Normal
NCT ID: NCT00000866 Org: User:
Start: - End: 07/31/99 Due: 07/31/00

The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

Phase: N/A Priority: Normal
NCT ID: NCT00000961 Org: User:
Start: - End: - Due: -

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

Phase: N/A Priority: Normal
NCT ID: NCT00000804 Org: User:
Start: - End: 08/31/02 Due: 08/31/03

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Phase: N/A Priority: Normal
NCT ID: NCT00000957 Org: User:
Start: - End: 08/31/93 Due: 08/31/94

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

Phase: N/A Priority: Normal
NCT ID: NCT00000742 Org: User:
Start: - End: 10/31/93 Due: 10/31/94

The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient

Phase: N/A Priority: Normal
NCT ID: NCT00000661 Org: User:
Start: - End: - Due: -

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir

Phase: N/A Priority: Normal
NCT ID: NCT00000697 Org: User:
Start: - End: - Due: -

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00000925 Org: User:
Start: 05/31/99 End: - Due: -

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Phase: N/A Priority: Normal
NCT ID: NCT00000885 Org: User:
Start: - End: 06/30/03 Due: 06/30/04

An HIV Vaccine Preparedness Study

Phase: N/A Priority: Normal
NCT ID: NCT00000915 Org: User:
Start: - End: - Due: -

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000666 Org: User:
Start: - End: 03/31/92 Due: 03/31/93

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Phase: N/A Priority: Normal
NCT ID: NCT00000848 Org: User:
Start: - End: 10/31/98 Due: 10/31/99